Explant model

  • Research type

    Research Study

  • Full title

    Human bone tissue for study the performance of bone plugs

  • IRAS ID

    192744

  • Contact name

    Chaozong Liu

  • Contact email

    Chaozong.Liu@ucl.ac.uk

  • Sponsor organisation

    The Royal National Orthopaedic Hospital

  • Duration of Study in the UK

    2 years, 11 months, 30 days

  • Research summary

    Treatments of osteochondral defects using tissue engineering methods have been established and are promising for the treatment of small osteochondral defects. In this approach, the use of 3D scaffolds (with or without cells) has been used to provide support for tissue growth. The osteochondral scaffold, which promotes the simultaneous regeneration of articular cartilage and underlining subchondral bone, is a key component for osteochondral tissue engineering and regenerative medicine.

    We have developed a novel osteochondral scaffold for large osteochondral defect repairs through EPSRC MeDe Innovation and ARUK PoC awards. Although in vivo animal studies have provided valuable information, however, greater variability in experimental results was reported due to the variations such as include species, locations, age and sex, size, and limited control of parameters in animal models. We believe that human explants from joint replacement surgery would provide more “realistic” biological environment than animal models. Evaluation of scaffolds using human explants would provide valuable and complementary information to animal models before clinical trials. This will speed up the translation of research into clinical practice.

    This project will develop a human explant model to evaluate the performance of osteochondral scaffolds developed through an ARUK proof of concept award using human explants, and to establish and validate the human explant models for osteochondral scaffold test.

  • REC name

    London - City & East Research Ethics Committee

  • REC reference

    15/LO/2052

  • Date of REC Opinion

    27 Nov 2015

  • REC opinion

    Further Information Favourable Opinion